{"url_path":"/sec/mcrb/8-k/2026-07-08/item-2","section_key":"item-2","section_title":"Item 2 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-08","source_url":"https://www.sec.gov/Archives/edgar/data/1609809/0001193125-26-298525-index.html","accession_number":"0001193125-26-298525","cik":"0001609809","ticker":"MCRB","issuer_name":"Seres Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1609809/0001193125-26-298525-index.html","primary_entity_key":"0001609809","primary_entity_name":"Seres Therapeutics, Inc."},"word_count":38,"has_tables":true,"body_markdown":"Item 2 - Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.\n\n \n\nVotes FOR\n  \nVotes AGAINST\n  \nVotes ABSTAINED\n  \nBroker Non-Votes\n\n4,542,915\n  \n267,601\n  \n174,660\n  \n0"}